The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman… - Blood, The Journal of …, 2009 - ashpublications.org
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - Blood, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immune thrombocytopenia (ITP) is mediated
by platelet autoantibodies that accelerate platelet destruction and inhibit their production …
by platelet autoantibodies that accelerate platelet destruction and inhibit their production …
The ITP syndrome: pathogenic and clinical diversity.
DB Cines, JB Bussel, HA Liebman, LP ET - Blood, 2009 - europepmc.org
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
[PDF][PDF] The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - management, 2009 - Citeseer
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
[HTML][HTML] The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - Blood, 2009 - ncbi.nlm.nih.gov
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
[PDF][PDF] The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - management, 2009 - researchgate.net
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
[引用][C] The ITP syndrome: pathogenic and clinical diversity
DB CINES, JB BUSSEL, HA LIEBMAN… - Blood, 2009 - pascal-francis.inist.fr
The ITP syndrome: pathogenic and clinical diversity CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - Blood, 2009 - pubmed.ncbi.nlm.nih.gov
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
[HTML][HTML] The ITP syndrome: pathogenic and clinical diversity
DB Cines, JB Bussel, HA Liebman, ETL Prak - Blood, 2009 - Elsevier
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …
The ITP syndrome: pathogenic and clinical diversity.
DB Cines, JB Bussel, HA Liebman, LP ET - Blood, 2009 - europepmc.org
Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …
platelet destruction and inhibit their production. Most cases are considered idiopathic …